Get App
Moneycontrol

Co-Partners

Associate Partners

Last Updated : May 17, 2019 09:31 AM IST | Source: Moneycontrol.com

Aurobindo Pharma falls 6% as USFDA classified inspection as OAI

The share touched its 52-week high Rs 838 and 52-week low Rs 527.05 on 30 April, 2019 and 04 June, 2018, respectively.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Share price of Aurobindo Pharma fell 6 percent in the early trade on Friday after USFDA classified the inspection as Official Action Indicated (OAI).

The company has received letters from the USFDA classifying the inspections concluded at its API facilities of Unit I and XI and intermediates facility of unit IX in February 2019 as Official Action Indicated (OAI).

The company has already submitted its initial response to USFDA, company said in release.

The company is sending further updates on the committed corrective actions.

The company is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

The share touched its 52-week high Rs 838 and 52-week low Rs 527.05 on 30 April, 2019 and 04 June, 2018, respectively.

Currently, it is trading 17.66 percent below its 52-week high and 30.93 percent above its 52-week low.

At 09:28 hrs Aurobindo Pharma was quoting at Rs 690.05, down Rs 34.75, or 4.79 percent on the BSE.

For more market news, click here

Get Lok Sabha 2019 Live Election Results, constituency-wise tally, news, views and analysis
Follow our Lok Sabha Election Result Live Blog here.
First Published on May 17, 2019 09:31 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant